KUC-7483 + Placebo + Tolterodine
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Overactive Bladder
Conditions
Overactive Bladder
Trial Timeline
— → —
NCT ID
NCT01004315About KUC-7483 + Placebo + Tolterodine
KUC-7483 + Placebo + Tolterodine is a phase 3 stage product being developed by Kissei Pharmaceutical for Overactive Bladder. The current trial status is completed. This product is registered under clinical trial identifier NCT01004315. Target conditions include Overactive Bladder.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01004315 | Phase 3 | Completed |
Competing Products
20 competing products in Overactive Bladder